Latest: Kirloskar Oil Engines Ltd Q1 FY27 results →All Q4 FY26 results →
KO

Kirloskar Oil Engines Ltd

Q4 FY26Industrial Products

Kirloskar Oil Engines Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management said on revenue, margins and capex.

Price₹2,101
Market cap₹32.6K Cr
P/E55.5
Updated23 Aug 2026
Read4 min read

The short version

KOEL aims to reach USD 2 billion in revenue by FY '30, reflecting steady, long-term growth. Kirloskar Oil Engines Limited is targeting sustained, long-term growth rather than short-term spikes.

From Kirloskar Oil Engines Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • KOEL aims to reach USD 2 billion in revenue by FY '30, reflecting steady, long-term growth.
  • Power Gen (PG) segment shows strong growth potential, focusing on high horsepower (HHP) engines and segments like construction, mining, and railways.
  • Industrial segment expected to contribute significantly, with multiple sub-segments having their own growth plans.
  • International business growth is sustainable with investments in building local presence and capabilities in specific markets.
  • Capacity expansions at plants (e.g., Kagal plant) to add 20,000 to 50,000 engine production capacity, expected to be operational by FY '28.
  • Introduction of new products such as Optiprime (units up to 3,000 kVA) and plans to increase capacity beyond 3,000 kVA.

2 more points from Kirloskar Oil Engines Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Kirloskar Oil Engines Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Announced a new capex of INR 1,400 crores targeting completion within the next 2 years (Pages 19, 13).
  • This capex focuses on capacity enhancement primarily for high horsepower (HHP) engines and includes building a new facility at existing Kagal land (Pages 19, 13).
  • Expected peak revenue potential from this capex is estimated at INR 5,000 to 6,000 crores, assuming an asset turn of 4 (Page 19).
  • Earlier, a capex of INR 700 crores was underway, focused on adding capacity for 50,000 engines, largely enhancing existing plant lines, expected to be operational around April next year (Pages 13, 9).
  • The asset turn for these capex investments is projected between 4% to 5% (Page 13).

2 more points from Kirloskar Oil Engines Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Industrial Products

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 1
2Shera Energy
Rev 1Mar 1
3
Rev 1Mar 1
4
Rev 1Mar 2
5
Rev 1Mar 2
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Kirloskar Oil Engines Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • NPCIL (Nuclear Power Corporation of India Limited) order execution timeline is by 2029.
  • The company is actively working on the NPCIL order, which is critical and tracked regularly to ensure timely delivery.
  • Revenue recognition for the NPCIL order has not started yet; billing-based revenue recognition will begin upon billing.

2 more points from Kirloskar Oil Engines Ltd's call on order book

Create a free account to keep reading this call

Kirloskar Oil Engines Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹2.1K Cr, net profit ₹155 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Industrial Products this season

  • Shubhshree Biofuels Energy Ltd (Q4 FY26)

    Long-term growth supported by increasing biomass blending mandates (from 5% to 30% by FY30). Key concall takeaways from Shubhshree Biofuels Energy Ltd's Q4…

  • Rappid Valves India Ltd (Q4 FY26)

    Capacity is well equipped to handle up to ₹120 crores in turnover without significant capex, focusing on higher-value valves rather than volume increase. Key…

  • United Heat Transfer Ltd (Q4 FY26)

    Current order book is approximately INR 36-37 crores (Page 11). Key concall takeaways from United Heat Transfer Ltd's Q4 FY26 earnings call — and how it ranks…

  • Aeron Composites Ltd (Q4 FY26)

    For H2 FY26, revenue from operations was ₹103 Cr; for H1 FY26, ₹118.8 Cr, totaling ₹221.8 Cr for FY26. Key investor presentation takeaways from Aeron Composites

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Kirloskar Oil Engines Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Kirloskar Oil Engines Ltd Q4 FY26 results?

KOEL aims to reach USD 2 billion in revenue by FY '30, reflecting steady, long-term growth. Kirloskar Oil Engines Limited is targeting sustained, long-term growth rather than short-term spikes.

What is Kirloskar Oil Engines Ltd share price analysis?

Kirloskar Oil Engines Ltd currently shows a neutral. The stock trades at a P/E of 55.5 with a market cap of ₹32,614 Cr. Investors should review the full earnings analysis for detailed insights.

Is Kirloskar Oil Engines Ltd planning capital expenditure?

Announced a new capex of INR 1,400 crores targeting completion within the next 2 years (Pages 19, 13).

Keep Kirloskar Oil Engines Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.